Oracle Pharma Ltd

All UK companiesHuman health and social work activitiesOracle Pharma Ltd

Other human health activities

Oracle Pharma Ltd contacts: address, phone, fax, email, website, shedule

Address: Apartment 45 26 Longleat Avenue B15 2EX Birmingham

Phone: +44-1453 9622894

Fax: +44-1453 9622894

Email: n\a

Website:

Shedule:

Incorrect data or we want add more details informations for "Oracle Pharma Ltd"? - send email to us!

Oracle Pharma Ltd detailed report: finance, accounts, vacancies. Get credit history, taxes and fees, banks accounts, tenders Oracle Pharma Ltd.

Registration data Oracle Pharma Ltd

Register date: 2010-04-15

Register number: 07225128

Type of company: Private Limited Company

Get full report form global database UK for Oracle Pharma Ltd

Owner, director, manager of Oracle Pharma Ltd

Omair Javed Director. Address: 26 Longleat Avenue, Birmingham, B15 2EX, United Kingdom. DoB: May 1986, British

Jobs in Oracle Pharma Ltd vacancies. Career and practice on Oracle Pharma Ltd. Working and traineeship

Engineer. From GBP 2500

Administrator. From GBP 2300

Director. From GBP 6000

Cleaner. From GBP 1000

Plumber. From GBP 2000

Fabricator. From GBP 2400

Responds for Oracle Pharma Ltd on FaceBook

Read more comments for Oracle Pharma Ltd. Leave a respond Oracle Pharma Ltd in social networks. Oracle Pharma Ltd on Facebook and Google+, LinkedIn, MySpace

Address Oracle Pharma Ltd on google map

The Oracle Pharma Ltd business has been in this business for six years, having launched in 2010. Started with registration number 07225128, Oracle Pharma is categorised as a Private Limited Company located in Apartment 45, Birmingham B15 2EX. This business is classified under the NACe and SiC code 86900 , that means Other human health activities. Oracle Pharma Limited reported its latest accounts up until 2013-04-30. The firm's most recent annual return was submitted on 2013-04-15.

Regarding this business, a variety of director's obligations have so far been fulfilled by Omair Javed who was chosen to lead the company in 2010.